NIH Program Announcements

  • Health Information Technology (IT) to Improve Health Care Quality and Outcomes (R21)
    (PA-17-246)
    Agency for Healthcare Research and Quality
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
  • Implementation and Evaluation of New Health Information Technology (IT) Strategies for Collecting and Using Patient-Reported Outcome (PRO) Measures (U18)
    (PA-17-247)
    Agency for Healthcare Research and Quality
    Application Receipt/Submission Date(s): September 25, 2017, September 25, 2018, and September 26, 2019), by 5:00 PM local time of applicant organization.
  • Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp)
    (PA-17-248)
    National Cancer Institute
    Application Receipt/Submission Date(s): June 15, 2017 by 5:00 PM local time of applicant organization.
  • Extracellular Vesicles and Substance Use Disorders (R21)
    (PAR-17-242)
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): August 15, 2017, January 16, 2018, August 15, 2018, January 15, 2019, August 15, 2019, January 15, 2020, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
  • Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01)
    (PAR-17-244)
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01)
    (PAR-17-245)
    National Cancer Institute
    Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III – Transitional Centers (P30)
    (PAR-17-249)
    National Institute of General Medical Sciences
    Application Receipt/Submission Date(s): May 26, 2017; May 28, 2018; and May 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Extracellular Vesicles and Substance Use Disorders (R01)
    (PAR-17-250)
    National Institute on Drug Abuse
    Application Receipt/Submission Date(s): August 15, 2017, January 16, 2018, August 15, 2018, January 15, 2019, August 15, 2019, January 15, 2020), by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s